Methods and compositions for ameliorating the symptoms of sepsis
US5730980A · kind A · utility
12Cited by
3References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 1994 |
| Grant date | Mar 24, 1998 |
| Priority date | — |
| Expiry date | Oct 25, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/545
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns a method of treating CD14-mediated host inflammatory response to LPS often associated with sepsis comprising administering a therapeutically effective amount of anti-CD14 antibody molecules. A therapeutic composition comprising anti-CD14 antibody molecules in a pharmaceutically acceptable excipient is also contemplated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.